Moreover, the administration of anti-TNF-α agents such as infliximab in rat models with induced arthritis has shown a partial restoration of CYP3A and CYP1A activity previously suppressed by the inflammatory state, as illustrated by an increase in CYP concentration and density (Figure 2) (35). This evidence concerns the gene CYP3A4 and arthritic joint disease.